Treating disorders by application of insulin-like growth factors and analogs
US5652214A · kind A · utility
32Cited by
6References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 1992 |
| Grant date | Jul 29, 1997 |
| Priority date | — |
| Expiry date | Oct 7, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/65
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of enhancing the survival of neuronal cells in a mammal, the cells being at risk of dying, the method including the step of administering to the mammal one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; a functional derivative of IGF-II; IGF-III; or a functional derivative of IGF-III.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.